N. Vardakis

525 citations

35 papers · 436 indexed · h-index 11

Impact in

Oncology top 10%
- Cancer Cells and Metastasis
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Pancreatic and Hepatic Oncology Research
- Cancer Treatment and Pharmacology
Cancer Research
- Cancer Genomics and Diagnostics

Papers in ⓘ

Oncology 30
- Cancer Treatment and Pharmacology 14
- Colorectal Cancer Treatments and Studies 12
- Lung Cancer Research Studies 8
- Cancer Cells and Metastasis 4
Pulmonary and Respiratory Medicine 20
- Lung Cancer Treatments and Mutations 14
- Gastric Cancer Management and Outcomes 4

Co-authors: Kostas Kalbakis (16 shared papers)John Souglakos (10 shared papers)S. Kakolyris (7 shared papers)D. Mavroudis (10 shared papers)Dora Hatzidaki (9 shared papers)Vassilis Georgoulias (8 shared papers)Sofia Agelaki (11 shared papers)Maria Perraki (4 shared papers)
Journals: Journal of Clinical Oncology (8 papers)Cancer Chemotherapy and Pharmacology (5 papers)Lung Cancer (4 papers)Annals of Oncology (4 papers)Clinical Lung Cancer (3 papers)
Partner nations: Greece United States Cyprus

In The Last Decade

N. Vardakis

33 papers receiving 417 citations

Peers

Countries citing papers authored by N. Vardakis

Since Specialization

Citations

This map shows the geographic impact of N. Vardakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Vardakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Vardakis more than expected).

Fields of papers citing papers by N. Vardakis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Vardakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Vardakis. The network helps show where N. Vardakis may publish in the future.

Co-authors

The 25 scholars most cited alongside N. Vardakis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with N. Vardakis Line = papers co-authored together N. Vardakis links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer Annals of Oncology ·Nikolaos Xenidis, Ioannis G. Vlachonikolis, D. Mavroudis, Maria Perraki, Aliki Stathopoulou, N. Malamos, Ch. Kouroussis, S. Kakolyris, Stella Apostolaki, N. Vardakis, Evi Lianidou, V. Georgoulias	2003	88
2	Frontline Treatment of Advanced Gastric Cancer With Docetaxel and Granulocyte Colony-Stimulating Factor (G-CSF) American Journal of Clinical Oncology ·Dimitriοs Mavroudis, C. Kourousis, N. Androulakis, Kostas Kalbakis, Sofia Agelaki, S. Kakolyris, John Souglakos, E. Sarra, N. Vardakis, Dora Hatzidaki, G. Sarmonis, Vassilis Georgoulias	2000	82
3	Paclitaxel plus bevacizumab in patients with chemoresistant relapsed small cell lung cancer as salvage treatment: A phase II multicenter study of the Hellenic Oncology Research Group Lung Cancer ·Giannis Mountzios, Christos Emmanouilidis, N. Vardakis, Emmanouil Kontopodis, Dora Hatzidaki, Evagelos Popis, Niki Karachaliou, Α. Kotsakis, M. Agelidou, Vassilis Georgoulias	2012	33
4	Phase I study of the gemcitabine/oxaliplatin combination in patients with advanced solid tumors: a preliminary report. PubMed ·D. Mavroudis, C. Kourousis, S Kakolyris, Sofia Agelaki, Kostas Kalbakis, N. Androulakis, John Souglakos, N. Vardakis, George Samonis, V Georgoulias	2000	29
5	Differential effect of adjuvant taxane-based and taxane-free chemotherapy regimens on the CK-19 mRNA-positive circulating tumour cells in patients with early breast cancer British Journal of Cancer ·N. Xenidis, Maria Perraki, Stella Apostolaki, Sofia Agelaki, Kostas Kalbakis, N. Vardakis, A. Kalykaki, Alexandros Xyrafas, Stylianos Kakolyris, D. Mavroudis, Vassilis Georgoulias	2013	25
6	Prognostic Significance of the Detection of Peripheral Blood CEACAM5mRNA-Positive Cells by Real-Time Polymerase Chain Reaction in Operable Colorectal Cancer Clinical Cancer Research ·N. Vardakis, Ippokratis Messaritakis, Chara Papadaki, Georgios Agoglossakis, Maria Sfakianaki, Zacharenia Saridaki, Stella Apostolaki, Ioannis E. Κoutroubakis, Maria Perraki, Dora Hatzidaki, Dimitris Mavroudis, Vassilis Georgoulias, John Souglakos	2010	22
7	Prognostic significance of CEACAM5mRNA-positive circulating tumor cells in patients with metastatic colorectal cancer Cancer Chemotherapy and Pharmacology ·Ippokratis Messaritakis, Maria Sfakianaki, Chara Papadaki, Asimina Koulouridi, N. Vardakis, Filippos Koinis, Dora Hatzidaki, Nefeli Georgoulia, Athina Kladi, Αthanasios Kotsakis, John Souglakos, Vassilis Georgoulias	2018	18
8	Docetaxel Vs. Vinorelbine in Elderly Patients With Advanced Non–Small-Cell Lung Cancer: A Hellenic Oncology Research Group Randomized Phase III Study Clinical Lung Cancer ·Athanasios Karampeazis, Lambros Vamvakas, Athina Agelidou, Nikolaos Kentepozidis, Kyriakos Chainis, Vassilis Chandrinos, N. Vardakis, Athanasios Pallis, Charalambos Christophyllakis, Vassilis Georgoulias	2011	17
9	Oxaliplatin in Combination with Infusional 5-Fluorouracil and Leucovorin Every 2 Weeks as First-Line Treatment in Patients with Advanced Colorectal Cancer: A Phase II Study Oncology ·Ch. Kouroussis, John Souglakos, Stylianos Kakolyris, D. Mavroudis, N. Malamos, Kostas Kalbakis, N. Androulakis, A. Agelaki, N. Vardakis, George Samonis, V. Georgoulias	2001	16
10	Oxaliplatin (L-OHP) combined with irinotecan (CPT-11), leucovorin (LV) and fluorouracil (5-FU) compared with irinotecan, leucovorin and fluorouracil as first-line treatment for metastatic colorectal cancer (MCC): Preliminary results of a multicenter randomized phase III trial Journal of Clinical Oncology ·John Souglakos, Nikolaos Ziras, Aris Polyzos, A. Athanasiadis, Stylianos Kakolyris, T. Giannakakis, E. Tselepatiotis, Kostas Kalbakis, N. Vardakis, Vassilis Georgoulias	2004	13
11	Efficacy and treatment tolerance in older patients with NSCLC: a meta-analysis of five phase III randomized trials conducted by the Hellenic Oncology Research Group Annals of Oncology ·Athanasios Pallis, Athanasios Karampeazis, L. Vamvakas, N. Vardakis, Αthanasios Kotsakis, V. Bozionelou, A. Kalykaki, Dora Hatzidaki, Dimitriοs Mavroudis, V. Georgoulias	2011	12
12	A Phase II Trial of Erlotinib As Front-Line Treatment in Clinically Selected Patients With Non–Small-Cell Lung Cancer Clinical Lung Cancer ·Athanasios Pallis, Alexandra Voutsina, Nikolaos Kentepozidis, Stylianos Giassas, Pavlos Papakotoulas, Sofia Agelaki, K. Tryfonidis, Αthanasios Kotsakis, Lambros Vamvakas, N. Vardakis, Vassilis Georgoulias	2011	8
13	Salvage treatment with irinotecan/cisplatin versus pemetrexed/cisplatin in patients with non-small cell lung cancer pre-treated with a non-platinum-based regimen in the first-line setting: a randomized phase II study of the Hellenic Oncology Research Group (HORG) Clinical & Translational Oncology ·Ν. Kentepozidis, Panagiota Economopoulou, Ch. Christofyllakis, Leonidas Chelis, Aris Polyzos, N. Vardakis, Filippos Koinis, L. Vamvakas, Panagiotis Katsaounis, Kostas Kalbakis, Ch. Nikolaou, V. Georgoulias, Αthanasios Kotsakis	2016	7
14	A Dose Escalation Study of Gemcitabine plus Pemetrexed Administered Biweekly in Patients with Solid Tumors Oncology ·A. Kalykaki, L. Vamvakas, Sofia Agelaki, Kostas Kalbakis, N. Vardakis, G. Sfakiotaki, M. Ignatiadis, Zacharenia Saridaki, Athanasios Karampeazis, D. Mavroudis, V. Georgoulias	2006	7
15	Salvage treatment of advanced non-small-cell lung cancer previously treated with docetaxel-based front-line chemotherapy with irinotecan (CPT-11) in combination with cisplatin Annals of Oncology ·S. Kakolyris, Ch. Kouroussis, Kostas Kalbakis, Dimitriοs Mavroudis, John Souglakos, N. Vardakis, S. Kremos, V. Georgoulias	2000	7
16	Docetaxel, gemcitabine and bevacizumab as salvage chemotherapy for HER-2-negative metastatic breast cancer Cancer Chemotherapy and Pharmacology ·Emmanouil Kontopodis, Nikolaos Kentepozidis, C. Christophyllakis, Ioannis Boukovinas, A. Kalykaki, Kostas Kalbakis, L. Vamvakas, Sofia Agelaki, Αthanasios Kotsakis, N. Vardakis, Vassilis Georgoulias, D. Mavroudis	2014	7
17	Second-line Paclitaxel/Carboplatin Versus Vinorelbine/Carboplatin in Patients Who Have Advanced Non–Small-Cell Lung Cancer Pretreated With Non–Platinum-Based Chemotherapy: A Multicenter Randomized Phase II Study Clinical Lung Cancer ·Athanasios Pallis, Kostas Syrigos, Αthanasios Kotsakis, Niki Karachaliou, Aris Polyzos, Vassilis Chandrinos, Ioannis Varthalitis, Charalambos Christophyllakis, Alexandros Ardavanis, Lambros Vamvakas, N. Vardakis, Zacharenia Saridaki, George Samonis, Stylianos Giassas, Vassilis Georgoulias, Sofia Agelaki	2011	6
18	A Dose-Finding Study of Irinotecan (CPT-11) plus a Four-Day Continuous 5-Fluorouracil Infusion in Advanced Colorectal Cancer Oncology ·S. Kakolyris, John Souglakos, Ch. Kouroussis, N. Androulakis, D. Mavroudis, Kostas Kalbakis, A. Kotsakis, N. Vardakis, M. Koukourakis, J. Romanos, V. Georgoulias	2001	5
19	Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG) Cancer Chemotherapy and Pharmacology ·Ioannis Boukovinas, Nikolaos Androulakis, Nikolaos Kentepozidis, Aris Polyzos, Pavlos Papakotoulas, Nikolaos Ziras, Αthanasios Kotsakis, N. Vardakis, Athanasios Karampeazis, Vassilis Markos, A. Kostakopoulos, C. Constantinides, George Samonis, Dimitris Mavroudis, Vassilis Georgoulias	2011	4
20	Salvage treatment in metastatic breast cancer with weekly paclitaxel and bevacizumab Cancer Chemotherapy and Pharmacology ·Aris Polyzos, Kostas Kalbakis, Nikolaos Kentepozidis, Stylianos Giassas, A. Kalykaki, N. Vardakis, V. Bozionelou, Emmanouil Saloustros, E. Kontopodis, Vassilis Georgoulias, Dimitris Mavroudis	2010	4

About N. Vardakis

N. Vardakis is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Molecular Biology, having authored 35 papers that have together received 436 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (14 papers), Lung Cancer Treatments and Mutations (14 papers), Colorectal Cancer Treatments and Studies (12 papers), Lung Cancer Research Studies (8 papers), Cancer Genomics and Diagnostics (5 papers), Cancer Cells and Metastasis (4 papers), Gastric Cancer Management and Outcomes (4 papers) and Breast Cancer Treatment Studies (3 papers). The work is most often cited by research in Oncology (348 citations), Cancer Research (113 citations), Pulmonary and Respiratory Medicine (201 citations), Gastroenterology (23 citations) and Hepatology (19 citations). N. Vardakis has collaborated with scholars based in Greece, United States and Cyprus. Frequent co-authors include Kostas Kalbakis, John Souglakos, S. Kakolyris, D. Mavroudis, Dora Hatzidaki, Vassilis Georgoulias, Sofia Agelaki, Maria Perraki, Stella Apostolaki and Ch. Kouroussis. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Lung Cancer, Annals of Oncology and Clinical Lung Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact